FACULTY RESEARCH

Faculty List

Hans David S. Ulmert, M.D., Ph.D.

Email Address: hulmert@mednet.ucla.edu

Department / Division Affiliations
Assistant Professor, Molecular & Medical Pharmacology

Research Interests
My program is focused on the study of risk factors and biomarkers related to clinically diagnosed cancer and definitive end-points in patient cohorts. The findings of these studies extend into my translational research, which center on development of novel in vivo strategies targeting proteins regulated by the molecular pathways that drive the disease. The overarching goal is to apply these specific tissue-targeting vehicles for multimodal molecular imaging strategies, as well as for carriers of therapeutic agents. I have successfully developed, validated and patented PET and SPECT technologies that are central to this application.


Publications

A selected list of publications:

Thorek Daniel L J, Ulmert David, Diop Ndeye-Fatou M, Lupu Mihaela E, Doran Michael G, Huang Ruimin, Abou Diane S, Larson Steven M, Grimm Jan   Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle Nature communications, 2014; 5: 3097.
Assel Melissa, Dahlin Anders, Ulmert David, Bergh Anders, Stattin Pär, Lilja Hans, Vickers Andrew J   Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening European urology, 2018; 73(6): 961-967.
Marciscano Ariel E, Ghasemzadeh Ali, Nirschl Thomas R, Theodros Debebe, Kochel Christina M, Francica Brian J, Muroyama Yuki, Anders Robert A, Sharabi Andrew B, Velarde Esteban, Mao Wendy, Chaudhary Kunal R, Chaimowitz Matthew G, Wong John, Selby Mark, Thudium Kent B, Korman Alan J, Ulmert David, Thorek Daniel Lj, DeWeese Theodore L, Drake Charles G   Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy Clinical cancer research : an official journal of the American Association for Cancer Research, 2018; .
Jiang Wen, Ulmert David, Simons Brian W, Abou Diane S, Thorek Daniel L J   The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates Nuclear medicine and biology, 2018; 62-63: 1-8.
Sjoberg Daniel D, Vickers Andrew J, Assel Melissa, Dahlin Anders, Poon Bing Ying, Ulmert David, Lilja Hans   Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men European urology, 2018; 73(6): 941-948.
Kim Kwanghee, Watson Philip A, Lebdai Souhil, Jebiwott Sylvia, Somma Alexander J, La Rosa Stephen, Mehta Dipti, Murray Katie S, Lilja Hans, Ulmert David, Monette Sebastien, Scherz Avigdor, Coleman Jonathan A   Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts Clinical cancer research : an official journal of the American Association for Cancer Research, 2018; 24(10): 2408-2416.
McDevitt Michael R, Thorek Daniel L J, Hashimoto Takeshi, Gondo Tatsuo, Veach Darren R, Sharma Sai Kiran, Kalidindi Teja Muralidhar, Abou Diane S, Watson Philip A, Beattie Bradley J, Timmermand Oskar Vilhemsson, Strand Sven-Erik, Lewis Jason S, Scardino Peter T, Scher Howard I, Lilja Hans, Larson Steven M, Ulmert David   Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer Nature communications, 2018; 9(1): 1629.
Assel Melissa J, Gerdtsson Axel, Thorek Daniel L J, Carlsson Sigrid V, Malm Johan, Scardino Peter T, Vickers Andrew, Lilja Hans, Ulmert David   Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project Oncotarget, 2018; 9(5): 5778-5785.
Alidori Simone, Thorek Daniel L J, Beattie Bradley J, Ulmert David, Almeida Bryan Aristega, Monette Sebastien, Scheinberg David A, McDevitt Michael R   Carbon nanotubes exhibit fibrillar pharmacology in primates PloS one, 2017; 12(8): e0183902.
Carlsson Sigrid, Assel Melissa, Ulmert David, Gerdtsson Axel, Hugosson Jonas, Vickers Andrew, Lilja Hans   Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study European urology, 2017; 71(1): 46-52.
Vilhelmsson Timmermand O, Larsson E, Ulmert D, Tran T A, Strand Se   Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2 EJNMMI research, 2016; 6(1): 27.
Thorek Daniel L J, Watson Philip A, Lee Sang-Gyu, Ku Anson T, Bournazos Stylianos, Braun Katharina, Kim Kwanghee, Sjöström Kjell, Doran Michael G, Lamminmäki Urpo, Santos Elmer, Veach Darren, Turkekul Mesruh, Casey Emily, Lewis Jason S, Abou Diane S, van Voss Marise R H, Scardino Peter T, Strand Sven-Erik, Alpaugh Mary L, Scher Howard I, Lilja Hans, Larson Steven M, Ulmert David   Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis Science translational medicine, 2016; 8(367): 367ra167.
Brea Elliott J, Oh Claire Y, Manchado Eusebio, Budhu Sadna, Gejman Ron S, Mo George, Mondello Patrizia, Han James E, Jarvis Casey A, Ulmert David, Xiang Qing, Chang Aaron Y, Garippa Ralph J, Merghoub Taha, Wolchok Jedd D, Rosen Neal, Lowe Scott W, Scheinberg David A   Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells Cancer immunology research, 2016; 4(11): 936-947.
Alidori Simone, Bowman Robert L, Yarilin Dmitry, Romin Yevgeniy, Barlas Afsar, Mulvey J Justin, Fujisawa Sho, Xu Ke, Ruggiero Alessandro, Riabov Vladimir, Thorek Daniel L J, Ulmert Hans David S, Brea Elliott J, Behling Katja, Kzhyshkowska Julia, Manova-Todorova Katia, Scheinberg David A, McDevitt Michael R   Deconvoluting hepatic processing of carbon nanotubes Nature communications, 2016; 7(11): 12343.
Abou Diane S, Ulmert David, Doucet Michele, Hobbs Robert F, Riddle Ryan C, Thorek Daniel L J   Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis Journal of the National Cancer Institute, 2016; 108(5): 27.
Brändstedt Johan, Almquist Martin, Ulmert David, Manjer Jonas, Malm Johan   Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case-control study Cancer causes & control : CCC, 2016; 27(1): 69-80.
Gerdtsson Axel, Poon Jessica B, Thorek Daniel L, Mucci Lorelei A, Evans Michael J, Scardino Peter, Abrahamsson Per-Anders, Nilsson Peter, Manjer Jonas, Bjartell Anders, Malm Johan, Vickers Andrew, Freedland Stephen J, Lilja Hans, Ulmert David   Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death European urology, 2015; 68(6): 1076-82.
Thorek Daniel L J, Kramer Robin M, Chen Qing, Jeong Jeho, Lupu Mihaela E, Lee Alycia M, Moynahan Mary E, Lowery Maeve, Ulmert David, Zanzonico Pat, Deasy Joseph O, Humm John L, Russell James   Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models International journal of radiation oncology, biology, physics, 2015; 93(2): 444-53.
Vilhelmsson-Timmermand Oskar, Santos Elmer, Thorek Daniel L J, Evans-Axelsson Susan, Bjartell Anders, Lilja Hans, Larson Steven M, Strand Sven-Erik, Tran Thuy A, Ulmert David   Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution Nuclear medicine and biology, 2015; 42(4): 375-80.
Ulmert David, Solnes Lilja, Thorek Daniel Lj   Contemporary approaches for imaging skeletal metastasis Bone research, 2015; 3(1): 15024.
Timmermand Oskar Vilhelmsson, Ulmert David, Evans-Axelsson Susan, Pettersson Kim, Bjartell Anders, Lilja Hans, Strand Sven-Erik, Tran Thuy A   Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6 EJNMMI research, 2014; 4(1): 51.
Doran Michael G, Spratt Daniel E, Wongvipat John, Ulmert David, Carver Brett S, Sawyers Charles L, Evans Michael J   Cabozantinib resolves bone scans in tumor-naïve mice harboring skeletal injuries Molecular imaging, 2014; 13(4): 375-80.
Carlsson Sigrid, Assel Melissa, Sjoberg Daniel, Ulmert David, Hugosson Jonas, Lilja Hans, Vickers Andrew   Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study BMJ (Clinical research ed.), 2014; 348(4): g2296.
Vickers Andrew J, Sjoberg Daniel D, Ulmert David, Vertosick Emily, Roobol Monique J, Thompson Ian, Heijnsdijk Eveline A M, De Koning Harry, Atoria-Swartz Coral, Scardino Peter T, Lilja Hans   Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen BMC medicine, 2014; 12(4): 26.
Svensson Charlotte, Ceder Jens, Iglesias-Gato Diego, Chuan Yin-Choy, Pang See Tong, Bjartell Anders, Martinez Roxana Merino, Bott Laura, Helczynski Leszek, Ulmert David, Wang Yuzhuo, Niu Yuanjie, Collins Colin, Flores-Morales Amilcar   REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer Nucleic acids research, 2014; 42(2): 999-1015.
Pesch Beate, Gawrych Katarzyna, Rabstein Sylvia, Weiss Tobias, Casjens Swaantje, Rihs Hans-Peter, Ding Hui, Angerer Jürgen, Illig Thomas, Klopp Norman, Bueno-de-Mesquita Bas, Ros Martine M, Kaaks Rudolf, Chang-Claude Jenny, Roswall Nina, Tjønneland Anne, Overvad Kim, Clavel-Chapelon Françoise, Boutron-Ruault Marie-Christine, Dossus Laure, Boeing Heiner, Weikert Steffen, Trichopoulos Dimitrios, Palli Domenico, Sieri Sabina, Tumino Rosario, Panico Salvatore, Quirós José Ramón, González Carlos, Sánchez Mariá José, Dorronsoro Miren, Navarro Carmen, Barricarte Aurelio, Ljungberg Börje, Johansson Mattias, Ulmert David, Ehrnström Roy, Khaw Kay-Tee, Wareham Nick, Key Timothy J, Ferrari Pietro, Romieu Isabelle, Riboli Elio, Brüning Thomas, Vineis Paolo   N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013; 22(11): 2055-65.
Makarov Danil V, Loeb Stacy, Ulmert David, Drevin Linda, Lambe Mats, Stattin Pär   Prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imaging Journal of the National Cancer Institute, 2013; 105(17): 1306-13.
Thorek Daniel L J, Evans Michael J, Carlsson Sigrid V, Ulmert David, Lilja Hans   Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles Thrombosis and haemostasis, 2013; 110(3): 484-92.
Tassidis Helena, Brokken Leon J S, Jirström Karin, Bjartell Anders, Ulmert David, Härkönen Pirkko, Wingren Anette Gjörloff   Low expression of SHP-2 is associated with less favorable prostate cancer outcomes Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2013; 34(2): 637-42.
Vickers Andrew J, Ulmert David, Sjoberg Daniel D, Bennette Caroline J, Björk Thomas, Gerdtsson Axel, Manjer Jonas, Nilsson Peter M, Dahlin Anders, Bjartell Anders, Scardino Peter T, Lilja Hans   Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study BMJ (Clinical research ed.), 2013; 346(17): f2023.
Rohrmann S, Linseisen J, Allen N, Bueno-de-Mesquita H B, Johnsen N F, Tjønneland A, Overvad K, Kaaks R, Teucher B, Boeing H, Pischon T, Lagiou P, Trichopoulou A, Trichopoulos D, Palli D, Krogh Vittorio, Tumino R, Ricceri F, Argüelles Suárez M V, Agudo A, Sánchez M-J, Chirlaque M-D, Barricarte A, Larrañaga N, Boshuizen H, van Kranen H J, Stattin P, Johansson M, Bjartell A, Ulmert D, Khaw K-T, Wareham N J, Ferrari Pietro, Romieux I, Gunter M J R, Riboli Elio, Key T J   Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition British journal of cancer, 2013; 108(3): 708-14.
Häggström Christel, Stocks Tanja, Ulmert David, Bjørge Tone, Ulmer Hanno, Hallmans Göran, Manjer Jonas, Engeland Anders, Nagel Gabriele, Almqvist Martin, Selmer Randi, Concin Hans, Tretli Steinar, Jonsson Håkan, Stattin Pär   Prospective study on metabolic factors and risk of prostate cancer Cancer, 2012; 118(24): 6199-206.
Ros Martine M, Bueno-de-Mesquita H Bas, Kampman Ellen, Büchner Frederike L, Aben Katja K H, Egevad Lars, Overvad Kim, Tjønneland Anne, Roswall Nina, Clavel-Chapelon Francoise, Boutron-Ruault Marie Christine, Morois Sophie, Kaaks Rudolf, Teucher Birgit, Weikert Steffen, von Ruesten Anne, Trichopoulou Antonia, Naska Androniki, Benetou Vassiliki, Saieva Calogero, Pala Valeria, Ricceri Fulvio, Tumino Rosario, Mattiello Amalia, Peeters Petra H M, van Gils Carla H, Gram Inger T, Engeset Dagrun, Chirlaque Maria-Dolores, Ardanazx Eva, Rodríguez Laudina, Amanio Pilar, Gonzalez Carlos A, Sánchez María José, Ulmert David, Ernström Roy, Ljungberg Börje, Allen Naomi E, Key Timothy J, Khaw Kee-Tee, Wareham Nick, Slimani Nadia, Romieu Isabelle, Kiemeney Lambertus A, Riboli Elio   Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition European journal of cancer (Oxford, England : 1990), 2012; 48(17): 3267-77.
Ulmert David, Vickers Andrew J, Scher Howard I, Becker Charlotte, Iversen Peter, Frankel David, Jensen Jens-Kristian, Olesen Tine Kold, Lilja Hans   Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses Clinical chemistry and laboratory medicine, 2012; 50(11): 1993-8.
Ulmert David, Kaboteh Reza, Fox Josef J, Savage Caroline, Evans Michael J, Lilja Hans, Abrahamsson Per-Anders, Björk Thomas, Gerdtsson Axel, Bjartell Anders, Gjertsson Peter, Höglund Peter, Lomsky Milan, Ohlsson Mattias, Richter Jens, Sadik May, Morris Michael J, Scher Howard I, Sjöstrand Karl, Yu Alice, Suurküla Madis, Edenbrandt Lars, Larson Steven M   A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index European urology, 2012; 62(1): 78-84.
Evans-Axelsson Susan, Ulmert David, Örbom Anders, Peterson Pernilla, Nilsson Olle, Wennerberg Johan, Strand Joanna, Wingårdh Karin, Olsson Tomas, Hagman Zandra, Tolmachev Vladimir, Bjartell Anders, Lilja Hans, Strand Sven-Erik   Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone Cancer biotherapy & radiopharmaceuticals, 2012; 27(4): 243-51.
Ulmert David, Evans Michael J, Holland Jason P, Rice Samuel L, Wongvipat John, Pettersson Kim, Abrahamsson Per-Anders, Scardino Peter T, Larson Steven M, Lilja Hans, Lewis Jason S, Sawyers Charles L   Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen Cancer discovery, 2012; 2(4): 320-7.
Klein Robert J, Hallden Christer, Gupta Amit, Savage Caroline J, Dahlin Anders, Bjartell Anders, Manjer Jonas, Scardino Peter T, Ulmert David, Wallström Peter, Vickers Andrew J, Lilja Hans   Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men European urology, 2012; 61(3): 471-7.
Jonsson Liv, Gaber Alexander, Ulmert David, Uhlén Mathias, Bjartell Anders, Jirström Karin   High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression Diagnostic pathology, 2011; 6(10): 91.
Syed Khaja Azharuddin Sajid, Helczynski Leszek, Edsjö Anders, Ehrnström Roy, Lindgren Anna, Ulmert David, Andersson Tommy, Bjartell Anders   Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcome PloS one, 2011; 6(10): e26539.
Lilja Hans, Cronin Angel M, Dahlin Anders, Manjer Jonas, Nilsson Peter M, Eastham James A, Bjartell Anders S, Scardino Peter T, Ulmert David, Vickers Andrew J   Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50 Cancer, 2011; 117(6): 1210-9.
Jakszyn Paula, González Carlos A, Luján-Barroso Leila, Ros Martine M, Bueno-de-Mesquita H Bas, Roswall Nina, Tjønneland Anne M, Büchner Frederike L, Egevad Lars, Overvad Kim, Raaschou-Nielsen Ole, Clavel-Chapelon Françoise, Boutron-Ruault Marie-Christine, Touillaud Marina S, Chang-Claude Jenny, Allen Naomi E, Kiemeney Lambertus A, Key Timothy J, Kaaks Rudolf, Boeing Heiner, Weikert Steffen, Trichopoulou Antonia, Oikonomou Eleni, Zylis Dimosthenis, Palli Domenico, Berrino Franco, Vineis Paolo, Tumino Rosario, Mattiello Amalia, Peeters Petra H M, Parr Christine L, Gram Inger T, Skeie Guri, Sánchez Maria-Jose, Larrañaga Nerea, Ardanaz Eva, Navarro Carmen, Rodríguez Laudina, Ulmert David, Ehrnström Roy, Hallmans Göran, Ljungberg Borje, Roddam Andrew Wilfred, Bingham Sheila A, Khaw Kay-Tee, Slimani Nadia, Boffetta Paolo A, Jenab Mazda, Mouw Traci, Michaud Dominique S, Riboli Elio   Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011; 20(3): 555-9.
Vickers Andrew J, Gupta Amit, Savage Caroline J, Pettersson Kim, Dahlin Anders, Bjartell Anders, Manjer Jonas, Scardino Peter T, Ulmert David, Lilja Hans   A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011; 20(2): 255-61.
Nyberg Martin, Ulmert David, Lindgren Anna, Lindström Ulla, Abrahamsson Per-Anders, Bjartell Anders   PCA3 as a diagnostic marker for prostate cancer: a validation study on a Swedish patient population Scandinavian journal of urology and nephrology, 2010; 44(6): 378-83.
Hagman Zandra, Larne Olivia, Edsjö Anders, Bjartell Anders, Ehrnström Roy A, Ulmert David, Lilja Hans, Ceder Yvonne   miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions International journal of cancer, 2010; 127(12): 2768-76.
Ruhayel Yasir, Giwercman Aleksander, Ulmert David, Rylander Lars, Bjartell Anders, Manjer Jonas, Berglund Göran, Giwercman Yvonne L   Male infertility and prostate cancer risk: a nested case-control study Cancer causes & control : CCC, 2010; 21(10): 1635-43.
Vickers Andrew J, Cronin Angel M, Björk Thomas, Manjer Jonas, Nilsson Peter M, Dahlin Anders, Bjartell Anders, Scardino Peter T, Ulmert David, Lilja Hans   Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study BMJ (Clinical research ed.), 2010; 341(6): c4521.
Savage Caroline J, Lilja Hans, Cronin Angel M, Ulmert David, Vickers Andrew J   Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010; 19(5): 1201-7.
Tassidis Helena, Brokken Leon J S, Jirström Karin, Ehrnström Roy, Pontén Fredrik, Ulmert David, Bjartell Anders, Härkönen Pirkko, Wingren Anette Gjörloff   Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer International journal of cancer, 2010; 126(10): 2296-307.
Ulmert David, O'Brien M Frank, Bjartell Anders S, Lilja Hans   Prostate kallikrein markers in diagnosis, risk stratification and prognosis Nature reviews. Urology, 2009; 6(7): 384-91.
Lilja Hans, Ulmert David, Vickers Andrew J   Prostate-specific antigen and prostate cancer: prediction, detection and monitoring Nature reviews. Cancer, 2008; 8(4): 268-78.
Ulmert David, Serio Angel M, O'Brien Matthew F, Becker Charlotte, Eastham James A, Scardino Peter T, Björk Thomas, Berglund Göran, Vickers Andrew J, Lilja Hans   Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008; 26(6): 835-41.
Ulmert David, Cronin Angel M, Björk Thomas, O'Brien Matthew F, Scardino Peter T, Eastham James A, Becker Charlotte, Berglund Göran, Vickers Andrew J, Lilja Hans   Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study BMC medicine, 2008; 6(6): 6.
Vickers Andrew J, Ulmert David, Serio Angel M, Björk Thomas, Scardino Peter T, Eastham James A, Berglund Göran, Lilja Hans   The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy International journal of cancer, 2007; 121(10): 2212-7.
Lilja Hans, Ulmert David, Björk Thomas, Becker Charlotte, Serio Angel M, Nilsson Jan-Ake, Abrahamsson Per-Anders, Vickers Andrew J, Berglund Göran   Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007; 25(4): 431-6.
Ulmert David, Becker Charlotte, Nilsson Jan-Ake, Piironen Timo, Björk Thomas, Hugosson Jonas, Berglund Göran, Lilja Hans   Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C Clinical chemistry, 2006; 52(2): 235-9.